Tuesday, 25 May 2021
Researchers have revealed for the first time that a peptide in a leading beauty product can penetrate the tough stratum corneum barrier of the skin.
A study between the 糖心原创 and No7, the UK’s number one skincare brand, used leading-edge technology to track the penetration of No7’s peptide blend Matrixyl 3000+™ following topical application to the skin surface. The findings offer an improved understanding of the bioavailability of topically applied peptides and provides further evidence for the efficacy of wrinkle targeting peptides.
Researchers used a tape-stripping method to remove layers of skin from study participants, in vivo, whilst maintaining the integrity of layers and structural features. A recently developed hybrid secondary ion mass spectrometry technique, 3D OrbiSIMS, was employed in the blinded study and detected the peptide penetrating into the tough stratum corneum barrier – the major obstacle and rate limiting step for the delivery of active ingredients into the skin (n=12; p<0.05 vs untreated).
The study used a recently popularised analytical technique to identify the peptide ten surface layers deep into the skin, whilst preserving the skin structure. Many other techniques rely on preparing skin samples for analysis by freeze-drying, fixing or staining, and therefore cannot be truly sure of the depth measured. “Never before have we been able to analyse the real-life penetration of the peptides in No7 in such detail,” writes Dr Mike Bell, No7 skincare scientific advisor:
For the first time, it has been possible to trace and detect the peptides responsible for tackling invisible photo-damage that occurs early in the ageing process. The 3D OrbiSIMS technique has opened up the possibility to track exactly where our peptides go to in the skin; now there are new insights into how to optimise delivery to make peptides even more effective.
David Scurr, Senior Research Fellow, School of Pharmacy
The flagship brand of the newly formed No7 Beauty Company, No7 was the first beauty brand in the UK to be able to demonstrate long term clinical and cumulative reductions in the appearance of lines and wrinkles on its Protect & Perfect Intense Advanced Serum. Since their creation, more than 5,000 women have been involved in the testing of all of No7’s serums across nearly 80 trials. In scientifically controlled clinical trials, over 90% achieved a visible reduction in the appearance of wrinkles. The company’s comprehensive approach to testing has proven that the serums dramatically slow the appearance of key signs of ageing, with advanced formulations that target damage; and now, its most recent testing with the 3D OrbiSIMS technique has given even greater insights into the powerful technology at the heart of the serums.
The 糖心原创 was the first University in the world to own and operate the 3D OrbiSIMS instrument. The technology facilitates an unprecedented level of molecular analysis for a range of materials including biological tissues, such as human skin. Importantly, its high mass resolving power, chemical specificity and high sensitivity allow it to be used on human skin samples to identify and analyse low concentrations of active ingredients that resemble native components of the skin, such as collagen peptides.
“This level of analysis of the Matrixyl 3000+™ peptide blend has not been possible until now. In the future, the technology may also allow us to identify new biochemical biomarkers of ageing and disease,” says Dr Mike Bell.
Story credits
More information is available from Dr David Scurr on David.Scurr@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.